10x Genomics TXG
NASDAQ TXG
$88.32 -2.04 (-2.26%)
As of: Oct 1, 2026 · 1:49 PM EDT

10x Genomics (TXG) Preferred Stock Liabilities (2018 - 2019)

Updated

10x Genomics (TXG) reported Preferred Stock Liabilities of $243.24 million for Q2 2019, unchanged from the prior quarter.

Analysis

10x Genomics (TXG) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

Dating back to Q3 2018, 10x Genomics' Preferred Stock Liabilities record includes 4 quarters.

  • By year, Preferred Stock Liabilities came in at $158.41 million in FY2017.
  • Per Business Quant data, the three quarters before Q2 2019 came in at $243.24 million (Q1 2019), $243.24 million (Q4 2018) and $208.29 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 10x Genomics 11.77 Bn 11.57 Bn 112.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 243.24 Mn
Mar 31, 2019 243.24 Mn
Dec 31, 2018 243.24 Mn
Sep 30, 2018 208.29 Mn
API Access

10x Genomics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TXG&period=max&api_key=YOUR_API_KEY